| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/16/2011 | EP2386304A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues |
| 11/16/2011 | EP2385989A1 Genetic variants useful for risk assessment of thyroid cancer |
| 11/16/2011 | EP2385955A2 Modified antibody compositions, methods of making and using thereof |
| 11/16/2011 | EP2385935A1 Compounds and uses thereof for treating inflammation and modulating immune responses |
| 11/16/2011 | EP2385934A1 Inhibitors of phosphatidylinositol-3-kinase (pi3) and inducers of nitric oxide (no) |
| 11/16/2011 | EP2385832A1 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
| 11/16/2011 | EP2385831A2 Small molecule inhibitors of nads, namnat, and nmnat |
| 11/16/2011 | EP2225243B1 Derivatives of N-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 11/16/2011 | EP2139482B1 Treatment for multiple myeloma |
| 11/16/2011 | EP2049154B1 Plasmid with immunological action |
| 11/16/2011 | EP2044952B1 Use of the pedf factor to induce cell regeneration |
| 11/16/2011 | EP2029627B1 Hepatocyte growth factor (hgf) binding proteins |
| 11/16/2011 | EP2003130B1 Novel pyridine derivative having anti-helicobacter pylori activity |
| 11/16/2011 | EP1978973B1 Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer |
| 11/16/2011 | EP1931676B1 Pyrazolopyrimidines as protein kinase inhibitors |
| 11/16/2011 | EP1899345B1 Pyrrolotriazine compounds useful as kinase inhibitors |
| 11/16/2011 | EP1899325B1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 11/16/2011 | EP1867673B1 Coordination compound composed of diaminocyclohexane platinum (ii) and block copolymer and anti-cancer agent comprising the same |
| 11/16/2011 | EP1746999B1 4-phenylamino-quinazolin-6-yl-amides |
| 11/16/2011 | EP1534340B1 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| 11/16/2011 | EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 11/16/2011 | EP1487458B1 Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 11/16/2011 | CN1901906B Cci-779 for treating mantle cell lymphoma |
| 11/16/2011 | CN1874790B Therapeutic agent for mesothelioma |
| 11/16/2011 | CN1706397B Composition of paeoniflorin and peony lactone glycoside with function of increasing leukocyte |
| 11/16/2011 | CN1650846B Elemene liposome and its preparation method |
| 11/16/2011 | CN102245766A Construction of protein-responsive shRNA/RNAi regulation system utilizing RNP motif |
| 11/16/2011 | CN102245758A Materials and methds to enhance hematopoietic stem cells engraftment procedures |
| 11/16/2011 | CN102245640A Anti-PD-L1 antibodies and their use to enhance T-cell function |
| 11/16/2011 | CN102245636A Etoposide and doxorubicin conjugates for drug delivery |
| 11/16/2011 | CN102245611A mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/P13K/AKT pathway |
| 11/16/2011 | CN102245610A Pyrrolotriazine kinase inhibitors |
| 11/16/2011 | CN102245609A Imidazopyridazinecarbonitriles useful as kinase inhibitors |
| 11/16/2011 | CN102245607A Morpholinopurine derivative |
| 11/16/2011 | CN102245597A Compounds useful for inhibiting CHK1 |
| 11/16/2011 | CN102245555A Isolate compounds from phaleria macrocarpa as anti cancer |
| 11/16/2011 | CN102245204A Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and intiviral, antibacterial, and anticancer agents |
| 11/16/2011 | CN102245184A Enzastaurin for the treatment of cancer |
| 11/16/2011 | CN102245175A Antitumor combination combining AVE8062 and docetaxel |
| 11/16/2011 | CN102245174A Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents |
| 11/16/2011 | CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product |
| 11/16/2011 | CN102242150A Heat shock protein-GP96 (HSP-GP96) recombinant adenovirus vector and construction method and application thereof |
| 11/16/2011 | CN102242127A Preparation method of serial antibacterial peptide Alloferon-1 and application of rAlloferon-1-K |
| 11/16/2011 | CN102242124A Modified Keratinocyte growth factor gene and its expression in yeast |
| 11/16/2011 | CN102242117A Aquaporin 4-siRNA interfering sequence, its fusion expression vectors and medicinal use of the fusion expression vectors |
| 11/16/2011 | CN102242116A Cytoskeletal binding protein siRNA (small interfering ribonucleic acid) interfering sequence, fusion expression vector thereof and medical application of same |
| 11/16/2011 | CN102242079A Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof |
| 11/16/2011 | CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof |
| 11/16/2011 | CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof |
| 11/16/2011 | CN102241969A Small-molecule fluorescent probes for quinazoline alpha1-adrenergic receptors and application of small-molecule fluorescent probes |
| 11/16/2011 | CN102241790A Amphipathic chitosan derivative and preparation method and application thereof |
| 11/16/2011 | CN102241785A Production technology of purslane polysaccharide |
| 11/16/2011 | CN102241777A Targeted PTEN gene composite, and preparation method and application thereof |
| 11/16/2011 | CN102241774A Recombinant IgE-Fc-anti EGFR single chain variable fragment fusion protein, its preparation method and its application |
| 11/16/2011 | CN102241773A Anti-myeloma cell polyclonal antibody and preparation method thereof |
| 11/16/2011 | CN102241758A Preparation method and medical application of cervical carcinoma associated trichina antigen antibody |
| 11/16/2011 | CN102241751A Novel fungal immunomodulatory protein FIP-NHA with antineoplastic activity and gene thereof |
| 11/16/2011 | CN102241726A Glycyrrhetinic acid derivative and application thereof as antitumor medicament |
| 11/16/2011 | CN102241710A Salidroside analogues as well as preparation method and application thereof |
| 11/16/2011 | CN102241693A N,N'-di-(1-methyl-beta-carboline-3-formyl)-lysly aminoacid benzyl esters, synthetic method thereof and application thereof |
| 11/16/2011 | CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 11/16/2011 | CN102241678A Antitumor effect and application of alicyclic structure-containing compound |
| 11/16/2011 | CN102241674A Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester |
| 11/16/2011 | CN102241672A 2,3-dipyrrolyl-6-acylaminoquinoxaline compounds and preparation method thereof |
| 11/16/2011 | CN102241665A 4-(4,5-dimethoxycarboxyl-1,3-dithiolane-2-yl)benzoyl-L-amino acid benzyl ester as well as synthesis method and applications thereof |
| 11/16/2011 | CN102241657A Synthesis of isoflavone compound through Stille crossed coupling reaction |
| 11/16/2011 | CN102241648A Multimedicine-resistance medicine-resistance taxane derivatives and preparation method and use thereof |
| 11/16/2011 | CN102241637A 2,3-diphenyl-6-amido quinoxaline compound and preparation method thereof |
| 11/16/2011 | CN102241633A Linolenic acid-carnosine composite and preparation method thereof |
| 11/16/2011 | CN102241625A 1-(substituted aryl)-5-((substituted arylamino) methyl) pyridine-2(1H) ketone compound, preparation method and use thereof |
| 11/16/2011 | CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof |
| 11/16/2011 | CN102241604A Amino acid modified curcumin, synthesis method thereof, and application thereof |
| 11/16/2011 | CN102241598A Monohydroxy emodin dioctyl quaternary ammonium salt with anticancer activity |
| 11/16/2011 | CN102241593A Protoilludance norsesquiterpenoid esters and uses thereof |
| 11/16/2011 | CN102240403A Method for preparing CaCO3 nanotube/podophyllum composite material |
| 11/16/2011 | CN102240394A Use of interleukin-1receptor antagonist (IL-1Ra), and pharmaceutical compositions of IL-1Ra |
| 11/16/2011 | CN102240381A Traditional Chinese medicine for treating esophageal cancer |
| 11/16/2011 | CN102240359A Traditional Chinese medicine for preventing and treating recurrence of esophageal cancer after radiotherapy and resisting side reactions of radiotherapy |
| 11/16/2011 | CN102240343A Environment-friendly preparation method for high-ester catechin tea polyphenol |
| 11/16/2011 | CN102240327A Method for extracting total anthraquinone in rhubarb from traditional Chinese medicine rhubarb by supercritical fluid |
| 11/16/2011 | CN102240306A Process for extracting proanthocyanidins from pine cone shells |
| 11/16/2011 | CN102240303A Production method of composite probiotics for preventing and treating intestinal cancer |
| 11/16/2011 | CN102240302A Chinese medicine composition of super gene active peptide |
| 11/16/2011 | CN102240298A Pharmaceutical composition for resisting tumors |
| 11/16/2011 | CN102240291A Imatinib-containing composition and preparation method thereof |
| 11/16/2011 | CN102240288A Application of N-substituted-3,5-dibenzal piperidine-4-one compounds |
| 11/16/2011 | CN102240274A Application of magnolol and honokiol in protein tyrosine phosphatase 1B inhibitor |
| 11/16/2011 | CN102240268A Sustained/controlled release microsphere of biological extract Genipin cross-linked chitosan coated stilbene compound and preparation method thereof |
| 11/16/2011 | CN102240267A Folate-receptor-mediated pH-sensitive Decoy-ODN (Decoy-oligodeoxynucleotide) nanoparticle preparation and preparation method thereof |
| 11/16/2011 | CN102240265A Liposome vector system for tumor-targeted drug delivery |
| 11/16/2011 | CN102239838A Terpenoid as well as preparation method and application thereof |
| 11/16/2011 | CN102038888B Anti-tumor medicament for promoting tumor cell senescence and preparation method thereof |
| 11/16/2011 | CN101966211B Application of dolichandrone cauda-felina in preparation of medicament for treating tumors |
| 11/16/2011 | CN101954049B Chinese medicinal preparation for treating liver neoplasms |
| 11/16/2011 | CN101940643B Medicament for treating gastric cancer and esophagus cancer |
| 11/16/2011 | CN101933904B Vinorelbine long circulation liposome preparation and preparation method thereof |
| 11/16/2011 | CN101926907B Method for preparing Kang'ai body resistance-strengthening tablets for treating tumors |
| 11/16/2011 | CN101919818B Method for preparing tetrandrine lung-targeted controlled-release microspheres |
| 11/16/2011 | CN101914536B Locked nucleic acid ribozyme of targeted serine-threonine protein kinase aurora kinase A and application thereof |
| 11/16/2011 | CN101891802B Polypeptide or derivative product for treating or preventing cancer and application thereof |